Type I borosilicate glass vial containing lyophilized powder, sealed with halobutyl rubber stopper and aluminum-plastic cap.

10 vials per box.

Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Tedizolid phosphate is indicated for the treatment of ABSSSI caused by susceptible Gram-positive bacteria, including:

Staphylococcus aureus (both MRSA and MSSA)

Streptococcus pyogenes

Streptococcus agalactiae

Streptococcus anginosus group (including S. anginosus, S. intermedius, S. constellatus)